Accelerate Your CNS Brand’s Growth in 2013
Companies with a strategic focus on CNS treatments understand the market is evolving. Increasing payer pressures, genericization of drug classes and heightened pricing and safety concerns require sales and marketing teams to demonstrate new levels of commercial savvy. The current dynamics of the CNS environment add significant complexity to successfully marketing your brand. To be profitable in today’s competitive market, …
Read MorePre-launch Excellence Drives Post-launch Profitability
As the CNS market evolves, brands are faced with new market realities, such as increasingly restricted access, heightened payer and pricing pressures, slowing overall market growth and complex analytic data sets. These current dynamics add significant complexity to successfully commercializing new CNS brands. Brand teams require more creativity and analytic know-how then ever before. A recent analyst report outlines three …
Read MoreTurning Data into Decisions
The current dynamics of the healthcare environment add significant complexity to partnering with and guiding your clients to achieve successful outcomes. This is especially true when launching new brands. Agency and client launch teams require more creativity and analytic know-how then ever before. In fact, a recent analyst report outlines three key areas that create winning launches: In addition to …
Read MoreQforma Awards 2013 Computational Thesis Honor
On May 3rd, Dr. Roger Jones, Qforma’s Co-Founder and Chief Executive Officer, presented the Qforma award for outstanding computational thesis or dissertation to Dr. Mark J. Olah. Mark, who recently received a degree of Doctor of Philosophy Computer Science at The University of New Mexico, was honored for his dissertation titled, “Multivalent Random Walkers: A computational model of superdiffusive transport …
Read MoreThe Patient-Driven Drug Pipeline
The new-drug pipeline is a mere shadow of its former blockbusting self. Despite the fact that R&D expenditures have been increasing over the last several years, the number of drugs in the pipeline has been decreasing. There have been many proposed explanations for this: a diminished margin for improvement that escalates the level of difficulty in proving drug benefits genomics …
Read MoreEmpower Your Data to Reveal Valuable Oncology Brand Insights
For many brands, data presents an immmense business challenge, hampering visibility and limiting access to important customer and market insights. This is especially true for oncology brands that are often plagued by “thin” data and complex data sets. Qforma can help your oncology brand gain actionable insights into physician practice activities and attributes. We can also assist your marketing and …
Read MoreAccelerate Your Oncology Brand’s Growth in 2013
Companies with a strategic focus on Oncology understand the market is changing, with increasingly restricted access, many tumors maturing and payers using new criteria to evaluate treatments. More then ever before, success in Oncology requires new levels of commercial savvy. The current dynamics of the oncology environment add significant complexity to successfully marketing your brands. To be profitable in today’s …
Read MoreMaximize Your Sales Efforts with Mobile Physician Insights
In today’s competitive market, sales and marketing leaders are under increasing pressure to improve field performance while at the same time manage sales costs. Many field teams are leveraging the efficiencies and presentation advantages offered by mobile devices. In fact, Manhattan Research reported that their “ePharma Physician 2012″ survey showed Apple iPad use by pharmaceutical sales representatives had doubled since …
Read MoreA Tutorial on the Regulation of the Pharmaceutical Industry
The pharmaceutical market place is not entirely a free market. The extreme demand for lifesaving products can make standard economic assumptions inoperable. Therefore, regulatory mechanisms have emerged to protect patients and to provide patients access to affordable medications. There are three aspects of pharmaceutical operations in the U.S. that are regulated by the government: The amount of business risk that …
Read MoreDrive Pre-launch Excellence to Enable Post-launch Success
The current dynamics of the oncology market add significant complexity to successfully commercializing new oncology brands. Brand teams require more creativity and analytic know-how then ever before. In fact, a recent analyst report outlines three key areas that create winning launches: In addition to the above factors, Qforma’s vast experience with supporting pre-launch oncology brands demonstrates the following capabilities are …
Read MoreTrending Industry News
Qforma newsletters offer compilations of trending industry topics, including the latest information on several disease states. Read More
